Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05825469
Other study ID # 22-637
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 1, 2024
Est. completion date December 31, 2024

Study information

Verified date January 2024
Source Dana-Farber Cancer Institute
Contact Marilyn Hammer, MD
Phone 617-632-1909
Email MarilynJ_Hammer@dfci.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this research study is to develop a nutrition algorithm to optimize nutritional status and improve quality of life during for participants who are completing or have completed cancer treatment. The name of the intervention used in this research study is: Nutrition Algorithm for Cancer Health Outcomes (NACHO) (a technology-based platform that houses the algorithms for the person-centered nutrition program)


Description:

This is a longitudinal, mixed-methods, pilot descriptive study to develop a nutrition algorithm for cancer patients based on the Cancer Nutrition Consortium (CNC) study findings and refined through a dietitian panel participants and from feedback from participants and Family Advisory Council (PFAC) members. Research study procedures include screening for eligibility, interviews and/or focus groups, dietitian panel meetings, and surveys. Participation in this study is expected to last about 12 months. It is expected about 130 people will participate in this research study.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 130
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria for Dietitians/Oncology clinicians - Have worked with at least 3 patients at the study site who had nutritional challenges Inclusion Criteria for Patient and Family Advisory Council (PFAC) participants - Current member of adult PFAC - > 18 years old Inclusion Criteria for Patient participants - > 18 years old - Able to speak and read English - Completed primary treatment (aim 2b) or actively undergoing treatment (aim 2b and aim 3, exploratory) - Access to a device (e.g., computer, tablet, smartphone) through which they can receive and engage with a REDCap link Exclusion Criteria for Patient Participants • Provider does not recommend

Study Design


Intervention

Behavioral:
Nutrition Algorithm
A technology-based platform for a person-centered nutrition program, providing suggested foods and recipes from dietitians.

Locations

Country Name City State
United States Dana Farber Cancer Institute Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Dana-Farber Cancer Institute Cancer Nutrition Consortium Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Nutrition Algorithm Primary study endpoint is development of a nutrition algorithm using the Cancer Nutrition Consortium (CNC) study findings and iteratively refine through an expert Dana-Farber Cancer Institute dietary panel along with consultations from oncology clinicians as needed and feedback from a panel of 4-6 Patient and Family Advisory Council (PFAC) members. Specific to data analyses, chi square, fisher's exact tests, and linear regression will be used to evaluate characteristics associated with changes in taste and different food preferences over time. Findings will inform the development of the algorithms. 12 months
Secondary Acceptability of Nutrition Algorithm for Cancer Health Outcomes (NACHO) Program Assessed using the System Usability Scale (SUS), a 10-item instrument with scores that range from 0-100 with higher scores representing greater usability. Acceptability is defined as a SUS score of >70. Up to 8 months
Secondary Participant Satisfaction Assessed using the Acceptability e-Scale (AES), a six-item scale that measures how easy, enjoyable, understandable, and helpful the intervention is. Total scores range from 6-30 with higher scores representing greater acceptability. Acceptability is defined as a AES score of >24. Up to 8 months
Secondary Panel member characteristics (Aims 1a, 1b, 2a, 2b) - Age Age group (i.e., 18-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80+) Up to 12 months
Secondary Panel member characteristics (Aims 1a, 1b, 2a, 2b) - Gender identity Gender identity (i.e., female, male, other____, prefer not to answer) Up to 12 months
Secondary Panel member characteristics (Aims 1a, 1b, 2a, 2b) - Ethnicity Ethnicity (i.e., Hispanic/Latinx / non-Hispanic/non-Latinx, prefer not to answer) Up to 12 months
Secondary Panel member characteristics (Aims 1a, 1b, 2a, 2b) - Race Race (i.e., Black, Caucasian, Asian, Native American, Pacific Islander, Alaska Native, multiracial, prefer not to answer) Up to 12 months
Secondary Panel member characteristics (Aims 1a, 1b, 2a, 2b) - Position Position / role and years in position (non-patient panel members only) (fill in) Up to 12 months
Secondary Characteristics of the cohort of 100 patients (Aim 3) - Age Age group (i.e., 18-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80+) Up to 12 months
Secondary Characteristics of the cohort of 100 patients (Aim 3) - Gender identity Gender identity (i.e., female, male, other____, prefer not to answer) Up to 12 months
Secondary Characteristics of the cohort of 100 patients (Aim 3) - ethnicity Ethnicity (i.e., Hispanic/Latinx / non-Hispanic/non-Latinx, prefer not to answer) Up to 12 months
Secondary Characteristics of the cohort of 100 patients (Aim 3) - race Race (i.e., Black, Caucasian, Asian, Native American, Pacific Islander, Alaska Native, multiracial, prefer not to answer) Up to 12 months
Secondary Characteristics of the cohort of 100 patients (Aim 3) - BMI Body mass index will will be calculated from weight in pounds and height in inches using the formula: weight (lb) / [height (in)]squared x 703 Up to 12 months
Secondary Characteristics of the cohort of 100 patients (Aim 3) - Comorbidities Comorbidities: Number of comorbidities (e.g., heart disease, diabetes) will be abstracted from electronic health records Up to 12 months
Secondary Global Health PROMIS-10 Global Health Questionnaire v.1.2 is an NIH-developed, valid and reliable instrument that will be used to assess functional status and quality of life. Higher scores represent better health. Scores will be computed to identify global physical and mental health component scores. Participant patients will complete this assessment at baseline, 2 months, and 5 months (visits 1, 3, and 6, respectively). T-scores will be used in the analysis to identify characteristics associated with other participant patients at the same global health levels. Changes in T-scores over time will be compared with changes in BMI and associated with utilization of the nutrition algorithm. Up to 12 months
Secondary Symptom Questions Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAETM) will be used to collect data on the occurrence, severity, and level of interference with daily activities for sleep quality (i.e., insomnia), pain, fatigue, and depression (i.e., anxiety, discouraged, sad) at baseline, 2 months, and 5 months (respectively visits 1, 3, and 6). Higher scores will indicate worse symptom experiences. T-scores will be used in the analysis to identify characteristics associated with other participant patients at the same global health levels. Changes in T-scores over time will be compared with changes in BMI and associated with utilization of the nutrition algorithm. Up to 12 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT06238557 - Prospective Evaluation of Psychological Consequences and Impact on Long-term Quality of Life
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT05472935 - Asynchronous Mindfulness Based Stress Reduction to Reduce Burnout in Licensed Clinical Social Workers N/A
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Active, not recruiting NCT04746664 - Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life in Bahir Dar City, North West Ethiopia N/A
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Active, not recruiting NCT05903638 - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT03813420 - Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level N/A
Recruiting NCT05550545 - Infant RSV Infections and Health-related Quality of Life of Families
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Recruiting NCT05233020 - Robotic Versus Hybrid Assisted Ventral Hernia Repair N/A
Terminated NCT03304184 - The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life Phase 3
Completed NCT05063305 - Probiotics, Immunity, Stress, and QofL N/A
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A